forced by recent a meta-analysis, 21 and it has been suggested that insomnia is a prodromal state of depression. 20 Thus, it appears more circumspect to refer simply to the temporal association between insomnia and mental disorder rather than to imply causality in either direction. Interestingly, however, diagnostic schedules for insomnia associated with mental disorder do not refer to any of the putative mechanisms for psychophysiologic insomnia.
There is a sizeable literature comparing people with insomnia and good sleepers across a range of cognitive, affective, and physiologic measures. 14 Surprisingly, however, there is little direct evidence of inadequate stimulus control or of conditioned arousal in bed as specific features of psychophysiologic insomnia. Furthermore, although there is some recent work of good quality on secondary insomnia, 22 to our knowledge, no study has compared insomnia associated with mental disorder with either psychophysiologic insomnia or good sleeper controls, using the descriptive self-report measures that are commonly used in insomnia research and practice. Thus, we do not have data on the sensitivity and specificity of this type of measurement. Research of this kind is important because we cannot assume discontinuity between the insomnias. Diagnostic systems, being categorical, tend to infer different underlying mechanisms and treatment responses, but evidence of such differences is unavailable.
Our aim was to investigate whether models that are applicable to psychophysiologic insomnia might also apply to sleep disturbance associated with mental disorder. More specifically, we wanted to explore self-reported behavioral, cognitive, and physiologic features to see if they evidenced continuity or discontinuity. This is a preliminary study of association rather than cause and effect. Nevertheless, because there are efficacious cognitivebehavioral treatments for persistent insomnia and effective pharmacologic treatments for short-term use, [23] [24] [25] [26] it is possible that insomnia therapies might be better targeted if distinctive features of insomnia could be established. Similarly, cognitive-behavioral treatments might be applied to sleep disturbance associated with mental disorder if we better understood the differential diagnosis from a conceptual perspective.
METHOD Design
The study comprised a between-subjects design with 3 independent groups: psychophysiologic insomnia (PI; n = 18), insomnia associated with mental disorder (I-MD; n = 18), and good sleepers (GS; n = 18). Between-group comparisons were made on measures of self-reported (subjective) and actigraphically estimated (objective) sleep and on self-report measures of sleeprelated behavior, thinking, and arousal.
Participants
The PI group had to meet combined DSM-IV/ICSD-R criteria, with the sleep pattern being assessed by sleep history and a selfreport sleep diary over 7 nights, 13 and (a) a sleep-onset latency (SOL) of more than 30 minutes, (b) a sleep efficiency (SE) of less than 85%, (c) frequent or extended nocturnal awakenings totaling more than 30 minutes of wakefulness after sleep onset (WASO), or (d) any combination of a, b and c, in each case occurring on at least 3 out of 7 nights per week for at least 1 month. Subjects were excluded from the PI group if they met criteria for any axis-I disorder or past major depressive episode (assessed by Structured Clinical Interview for DSM-IV axis-I Disorders (SCID-I) 27 or had any evidence on our locally derived screening measures of sleeprelated breathing disorder or periodic limb movements in sleep. Additionally, they were excluded if they had a Beck Depression Inventory (BDI) 28 score of 20 or more, 29 or had any physical or medical problems causing insomnia (as defined in ICSD-R). Thirty consecutive potential participants, complaining of significant and persistent sleep disturbance, were identified through attendance at clinical psychology outpatient services. Of these, 7 failed to complete screening, 3 failed to attend, and 2 were excluded because they did not meet insomnia criteria (final n =18).
Participants with I-MD had to satisfy the same sleep disturbance criteria, meet DSM-IV criteria (SCID-I) for major depressive disorder, and obtain a score of ³ 20 on the BDI. These participants were initially intended to form an "insomnia associated with depression" group, but, because of the high comorbidity of depressive and anxiety disorders, a more general title has been applied. Operationally, I-MD should be taken to mean "insomnia associated with mental disorder (depressed/anxious)." We excluded other individuals who met criteria for other axis-I disorders if they had medical problems causing sleep disturbance, any clinical evidence of sleep-related breathing disorder or periodic limb movements of sleep, or if their only sleep problem was early morning wakening. This latter criterion was to increase comparability of sleep-symptom complaint between the PI and I-MD groups. The Beck Anxiety Inventory (BAI) 30 was also applied descriptively to assess severity of anxiety symptoms (all groups). Thirty-two individuals were identified through mental health services or general practice surgeries, of whom 2 failed to complete screening, 2 did not attend, 2 failed to return measures, and 8 were excluded (1 mild mental retardation, 1 medical complaint causing insomnia, 4 did not meet criteria for depressive disorder, and 2 had additional axis-I diagnoses), leaving 18 in the I-MD group.
The GS group was recruited as an opportunity sample. Eighteen out of 20 nonclinical volunteers participated (2 excluded due to temporary illness causing sleep disruption). All had (a) SOL < 30 minutes; (b) SE > 85%; (c) WASO totaling < 30 minutes, in each case occurring on at least 5 out of 7 nights per week as measured by the sleep diary; and (d) regarded themselves as a good sleeper.
Measures and Procedure
Following screening, participants completed a 7-night sleep diary 13 while concurrently wearing an actigraph on the nondominant wrist to provide an objective estimate of sleep. Actiwatch-R â Model AW4 (Cambridge Neurotechnology Ltd., Cambridge, UK) devices were used with epochs of 1 minute selected for accurate sleep analysis. 31 Actigraphs had event markers, which participants pressed when they went to bed and when they got up. Objective estimates of SOL, WASO, total sleep time (TST), and SE were recovered using Sleepwatch â software (Cambridge Neurotechnology, Ltd.), and parallel data were derived from the sleep diaries.
A set of self-report measures was selected to best reflect presumed underlying mechanisms in insomnia. Participants completed these measures at home and returned them with their sleep diaries and actigraph. The Sleep Behavior Self-Rating Scale (SBSRS) 32 assesses sleep-incompatible behaviors associated with a person's bed or bedroom and is the only published scale to quantify the stim-ulus-control paradigm. Test-retest correlation (r = .88) and internal consistency data (K-R 20 = .70) indicate acceptable reliability, and the original authors reported good discriminant validity 32 . However, we revised the scale (SBSRS-R) to more fully address stimuluscontrol principles. Seven items were added, based on Bootzin's revision of his stimulus-control instructions. 7 For example, "I take naps during the day or evening" and "If I can't get to sleep within about 20 minutes I get up and move to another room until I feel sleepy again" were added, and 14 previous items that simply repeated statements, first in relation to "around sleeping time" and second to "during the day," were reduced to 7 by amending the instructions for the questionnaire. The revised SBSRS-R a , therefore, had 14 items rated, as in the original, on a 5-point Likert scale from never to very often (α = .69 this study, n = 53).
The Pre-Sleep Arousal Scale (PSAS) 9 is a 16-item questionnaire that yields separate scale scores for physiologic arousal and cognitive arousal. Both scales have acceptable internal consistency (PSASphysiol: α =. 84 and 0.81 for good sleepers and insomniacs respectively; PSAScog: α = .67 and .76). Evidence for the construct validity of the PSAScog scale comes from studies where presleep intrusive thoughts have been directly audiotape recorded. 33 The PSAS is rated on a 5-point scale from 1 (not at all) to 5 (extremely), with items reflecting autonomic arousal on the PSASphysiol scale (eg, heart racing/pounding, tight/tense muscles) and mental arousal on the PSAScog (eg, worry about not falling asleep, being mentally alert).
A number of other measures relevant to cognitive arousal were also completed. These were the Sleep Disturbance Questionnaire (SDQ) 10 , the Glasgow Sleep Effort Scale (GSES) 34 and the Dysfunctional Beliefs and Attitudes about Sleep scale-10-item version (DBAS-10). 29 The SDQ is a 12-item questionnaire to identify causal attributions concerning perceived sources of a sleep problem (α = .82). Items are rated on a 5-point scale from never true to very often true (eg, "I am unable to empty my mind"). The subscale "attributions concerning mental overactivity" was utilized in this study. The GSES was developed in response to the poor face and construct validity of an existing measure, the Sleep Anxiety Scale. 35 The GSES is a 7-item scale designed to measure elements of a general model of effortful preoccupation with sleep (ie, effort to sleep, attempts to control sleep, worry over failure to sleep). It is rated on a 3-point scale (very much, to some extent, not at all) and has acceptable internal consistency (α = .70) . 34 The DBAS-10 is a short-form version of an original 30-item scale measuring salient, affect-laden, irrational beliefs concerning the process of sleep. 36 The 10-item version is scored on 10-cm analogue lines from strongly disagree to strongly agree (α =. 69), 29 based on items shown to be sensitive to change after cognitive-behavioral therapy. The validity of the DBAS-10 has been recently supported. 37 Finally, we included a measure of sleep hygiene. The Sleep Hygiene Awareness and Practice Scale (SHAPS) 38 has 19 items, and respondents are asked to state on how many nights per week they typically go to bed hungry, take caffeine within 4 hours of bedtime, exercise within 2 hours of bedtime, have their sleep disturbed by noise, etc. The original authors demonstrated that insomniacs practiced poorer sleep hygiene than good sleepers, and the SHAPS has been widely used both in clinical settings and in research.
RESULTS

Descriptive and Clinical Variables
There were proportionately more women in the PI group (PI = 4 men/14 women, I-MD = 7 men /11 women, GS = 8 men /10 women); however, this difference was not statistically significant [χ 2 (2, n = 54) = 2.11, P = .35]. Participants ranged from 21 to 64 years of age, and average age per group was late 30s or early 40s (Table 1) . Both PI and I-MD groups reported insomnia of over 9 years in duration. As expected, I-MD participants had significant- ly higher symptomatology on the BDI (mean = 28.6), 15 of 18 were on antidepressant medication (compared with 1 in the PI and 0 in the GS groups), and 15 attended mental health services (compared with 0 in the PI or GS groups). PI participants scored lower on the BDI (mean = 8.4) but, nevertheless, significantly higher than the GS group. Recent BDI data from 139 of our clinic-presenting insomniacs suggest comparability with the present PI group (mean = 10.9, SD = 9.12). 29 An independent rater listened to a random sample of 3 audiotaped SCID-I interviews for each group (PI, I-MD, GS), and ratings for each item in each interview were compared. Cohen's k showed that, overall, the ratings made were identical (k = 1.00). Six individuals in the I-MD group had a comorbid anxiety diagnosis of generalised anxiety disorder, 6 had a diagnosis of social phobia, 7 had a diagnosis of panic disorder with agoraphobia, and 2 had a diagnosis of specific phobia. Seven participants had more than 1 comorbid diagnosis. Only 1 participant in the PI group and 2 in the I-MD group were on hypnotic medication, and the I-MD group scored considerably higher on BAI symptoms than did either the PI or GS groups (Table 1) .
Sleep Variables
Several sleep variables exhibited nonnormal distributions, and the Levine statistic revealed that group variances on some measures were not equal. However, analysis of variance is relatively robust when normality assumptions are violated, and in the case of unequal variances, unless sample sizes are unequal. 39, 40 Analysis of variance models, therefore, were applicable to our data. Multivariate analyses of variance were applied to compare sleep-pattern variables between groups. The 4 sleep-diary variables (SOL, WASO, TST, SE) were entered into 1 model, and this procedure was repeated for the same 4 actigraphic variables. There was a significant effect of the factor variable (Wilks' l) for both sleep diary and actigraphic variables (F 8,96 = 4.22 , P < .001 and F 8,96 = 2.64, P < .01, respectively). Separate analyses of variance were then applied to investigate between-group differences on specific sleep variables ( Table 2 ).
The GS group had significantly lower diary reports of SOL and WASO and significantly greater TST and higher SE than either the PI or I-MD groups. There were no significant differences between the insomniac groups on self-reported sleep. Both the PI and I-MD groups took more than 40 minutes to fall asleep, had around 1 hour of wakefulness during the night, and had SEs around 75% (Table 2) . Interestingly the PI group reported sleeping on average less (5 hours 43 minutes) than the I-MD group (6 hours 21 minutes), but this difference was not statistically significant using conservative posthoc testing. Although the omnibus multivariate analyses of variance test also suggested significant between-group differences in actigraphic sleep, no significant between-group differences emerged for WASO or TST ( Table 2 ). The I-MD group exhibited significantly greater SOL than the control group, and the PI group had a significantly higher SE than the I-MD group. Product-moment correlations were carried out to investigate the relationship between sleep-diary and respective actigraphic variables across groups. Only the correlation coefficient for SOL was statistically significant for the total group (n = 54: SOL: r = .62, P < 0.01; WASO: r = .04, P > 0.10; TST: r = .17, P > 0.10; SE: r = .13, P > 0.10). Within-group subjective/ actigraphic association was significant in I-MD participants for SOL (r s = .691, P = .002: n = 18), and in GS participants for TST (r s = .577, P = .012: n = 18).
Rating-Scale Variables Measuring the Insomnia Experience
One participant failed to complete the SBSRS-R, and 3 the DBAS-10. A series of 7, 1-way analyses of variance was applied, the results of which are presented in Table 3 . Due to the multiple comparisons made, Bonferroni correction resulted in the critical value for significance of P = .007 (.05/7).
No significant differences between insomniacs (PI, I-MD) and GS were observed on the SBSRS-R, suggesting that the frequency of engagement in sleep-incompatible activities was equivalent across groups. The I-MD group, however, did exhibit poorer sleep hygiene practices (SHAPS) relative to both the PI and GS groups, and, similarly, the PI group had poorer sleep hygiene than the GS group. The GS and PI groups did not differ from one another on PSASphysiol, but both reported significantly less physiologic arousal than did the I-MD group. By comparison, however, both insomniac groups reported greater cognitive arousal (PSAScog) than the GS, although the I-MD group had higher scores than the PI group. Both insomniac groups again scored significantly higher than the GS group on the SDQ (attributions to cognitive arousal) and the DBAS-10 (dysfunctional cognitions regarding sleep), but the PI and I-MD groups did not differ from each other on either of these measures. Finally, on the GSES, I-MD and PI participants reported higher levels of sleep effort than GS, but the I-MD group also scored significantly higher than the PI group. The preceding analyses, therefore, indicate between-group differences on 6 of the 7 variables studied. However, possible relationships among variables need to be considered. Therefore, a correlation matrix was calculated comprising participants from the 2 insomnia groups (Table 4) , which also included depression and anxiety scale scores. Inspection of Table 4 demonstrates that pairings of scores for the majority of variables, with the general exception of those involving sleep behavior (SBSRS-R) and sleep hygiene (SHAPS), were significantly intercorrelated (r > .33). It is particularly noteworthy that measures of presleep arousal (PSASphysiol, PSAScog) and psychopathology (BAI and BDI) were associated (r >= .56). The correlation between BAI and PSASphysiol was r = .87.
If we are to understand the relative influence of these variables, and how they may interact, a multivariate model is required. This also helps to address the fact that our measures share method variance (self-report ratings). Thus, separate logistic-regression analyses were conducted for each of the comparisons of interest-PI/GS, I-MD/GS and PI/I-MD. These analyses should be interpreted cautiously because of the small sample sizes. Nevertheless, our aim was to identify which variable or subset of variables might best discriminate between groups and, so, to suggest lines of inquiry for future study. Variables were entered in a forward stepwise model.
For the discrimination of psychophysiologic insomnia from good sleep (PI/ GS), sleep effort (GSES) entered on the first step (B = 11.85, standard error B = 108.0), correctly identifying 100% of PI (sensitivity) and 94% of GS (specificity) (χ 2 = 44.67, df = 1, P < .001). No other variable added to this discrimination. Similarly, GSES entered as the only predictor for the I-MD/GS comparison (B = 8.66, standard error B = 2055.5), correctly allocating 100% of cases to I-MD and GS groups, respectively (χ 2 = 44.24, df = 1, P < .001). For the prediction of PI versus I-MD insomniacs, only BDI score entered (B = 28.90, standard error B = 1374.4), again correctly allocating 100% of cases (χ 2 = 45.48, df = 1, P < .001), suggesting that symptomatic mood was the critical between-group factor here, rather than any insomnia specific variable.
DISCUSSION
Our purpose was to explore explanatory mechanisms for psychophysiologic insomnia by investigating the sensitivity and specificity of commonly used insomnia research tools in the discrimination of PI from I-MD and from good sleep. We found no between-group differences on a measure of sleep-related stimulus control, and self-reported somatic arousal was higher in I-MD than either GS or PI. Both I-MD and PI had poorer sleep hygiene and were particularly characterized by heightened mental arousal. Our measure of "effortful preoccupation with sleep" best discriminated both PI and I-MD from GS, but only depressive symptomatology discriminated I-MD from PI. These results were drawn from a small sample in this preliminary exploratory study. Accordingly, they should be interpreted cautiously and require replication using larger samples and samples in which the nature and severity of depressive and comorbid anxiety disorders can be specifically studied.
First, our results confirm that both insomnia groups slept poorly relative to GS, according to self-report sleep-diary data. Mean SE for the PI and I-MD groups was around 77%, compared with 96% in the GS group, respectively, which are 10% below and 10% above the recognized "cut-off" for sleep disorder. 41 This pat- tern was reflected also in symptom measures of "initial insomnia," "sleep-maintenance insomnia," and "insufficient sleep" (DSM-IV) because people with insomnia took significantly longer to fall asleep (40-50 minutes compared with 10 minutes), were more wakeful in the night (around 60 minutes compared with 5 minutes), and slept less than GS (around 6 hours compared with 7 hours 30 minutes). PI and I-MD groups did not differ from each other on sleep self-reports. As expected, however, the former had higher scores for depressive symptoms on the BDI (> 2 SD higher than for PI). Mean BDI score for PI participants was below the clinical range. Symptomatic anxiety on the BAI was also greater in the I-MD group. Furthermore, the majority of the I-MD group were on antidepressant pharmacotherapy and in contact with mental health services. While these data on between-group differences suggest that our selection and allocation to experimental groups (GS, PI, I-MD) were valid, they also reveal an important confound that should be taken into account in interpreting our results. The nearly universal use of antidepressants in the I-MD group implies that this is in effect a "treated I-MD" group, albeit with a relatively high mean BDI score of 28. Future research, therefore, needs to include an "untreated" I-MD group to control for the effects of medication use. It would also be helpful to separately consider treatment responsive and nonresponsive cohorts in future studies.
In comparison with self-report, actigraphic data generally failed to confirm between-group differences in sleep, and correlation with diary measures was low in all 3 groups. SE was estimated in the range of 80% to 87% across groups, and overall association between subjective and objective data was r = .13 (n = 54). Most strikingly, participants in the GS group who had no history of sleep disorder; no current sleep complaint; and, by their own report, slept well during the study week provided actigraphic data suggesting that they slept only around 6 hours (selfreport 7.5 hours) and that they had an average of 50 minutes of wakefulness per night (self-report 5 minutes). These results, like those from another report, 42 therefore, are strongly suggestive of validity problems with this form of measurement.
Second, the ICSD-R suggests that in PI, sufferers engage in sleep-incompatible behavior in the bedroom. However, our results evidence no differences in such behavior between GS and either PI or I-MD. It is, of course, possible that our measure of sleep-incompatible behavior (SBSRS-R) was inadequate. More plausible perhaps is the possibility that the same behaviors present, even with similar frequency, but that they have different consequences for good and poor sleepers. Thus, and for example, reading in bed may have a sleep-preventing effect only for poor sleepers. Nevertheless, our findings are consistent with early reports where insomniacs and GS exhibited similar sleep behavior 43 and where experimental intervention, using components of stimulus-control treatment, suggested that the bed becoming a "discriminative stimulus for sleep" was not the active mechanism. 44 In the only recent study, people with insomnia were found not to differ from GS on daytime napping, sleep scheduling, whether they stayed in bed or got up when unable to sleep, or on engagement in sleep-incompatible activities. 45 Third, according to the ICSD-R, PI is also characterized by conditioned physiologic arousal. This study focused upon selfreport, so no direct measurement was taken of autonomic or cortical arousal. The physiologic arousal subscale of the PSAS, nevertheless, is widely used, and, interestingly, we found that only I-MD differed from GS on this measure. This suggests that somatic arousal may be more characteristic of patient report where insomnia is associated with mental disorder. It should be noted, however, that many of our I-MD participants had symptoms of anxiety and that we found a strong positive correlation between PSASphysiol and state anxiety on the BAI (r = .89). The association of physiologic and anxiety symptoms in our I-MD sample could account for our results. Alternatively, there may be problems with the construct validity of this subscale of the PSAS, if it is simply a proxy for somatized anxiety. Further evidence on physiologic arousal may come from our data on the SHAPS because it has been argued that inadequate sleep hygiene delays sleep onset primarily through heightened arousal. 14 For example, caffeine produces increased arousal on metabolic measures and reports typical of insomniac complaint. 46 In the present study, sleep-hygiene practice was found to differ across the experimental groups, with I-MD having higher SHAPS scores (poorer practices) than either GS or PI, and PI having higher scores than GS.
Fourth, not all objective poor sleepers complain of insomnia, and not all subjective insomniacs have poor sleep, 47 suggesting that physiologic arousal alone may be an insufficient explanation of insomnia. We found that the I-MD group reported greater mental arousal than the PI group on the PSAScog and that both I-MD and PI groups reported more mental arousal than the GS. Insomniac thoughts during the presleep period are often worried and negative in content. 48, 35 Perhaps people with insomnia associated with depression or anxiety appraise things even more negatively than do psychophysiologic those with PI? It is interesting, therefore, that the DBAS-10 results tend to confirm the PSAScog findings. Both PI and I-MD groups scored more than 2 SD higher than GS on this measure, and, although the mean score for I-MD was not significantly higher than for PI, the trend again was in that direction. It seems then that people with insomnia may be more prone to sleep-related thinking errors than are GS. This finding was further reinforced by our data from the SDQ, where both PI and I-MD groups had higher scores on a measure of causal attribution concerning mental overactivity in bed.
Moreover, with respect to mental arousal, our data from the GSES are particularly interesting. They reflect a similar distinction, in terms of severity, between I-MD and PI, with both groups exhibiting higher sleep effort that the GS group. However, our analyses suggest that an explanatory model including "effortful preoccupation with sleep" may be of special importance in understanding the cognitive arousal associated with insomnia. We observed strong intercorrelations among our variables measuring arousal, despite these being supposedly differing constructs, perhaps indicating that a common underlying insomnia construct may exist. We then found that logistic-regression models identified the GSES as the best measure to discriminate insomniacs from GS. Furthermore, this effect applied for both the PI and the I-MD groups, yielding 100% sensitivity in both cases and 94% and 100% specificity for each respectively. This result, when coupled with evidence that I-MD and PI groups were perfectly differentiated using BDI scores alone, without recourse to measures of sleep-related behavior or cognition, suggests that a continuum may exist across "primary" and "secondary" insomnia (at least where it is associated with depression or anxiety). This suggestion is supported by other recent work on symptom reports in patients with severe chronic insomnia, which have found that "depression-related insomnia" and PI were separable only by characteristic symptoms of depression. 49 A caveat must be introduced, however, in relation to the fact that the BDI discriminated so well. Our patients with PI were excluded for high BDI scores, and I-MD patients were included partly on this basis. Therefore, although valid from a diagnostic standpoint, our BDI results do not reflect an independent observation in this study.
PI and I-MD, therefore, may have much in common. They may have similar mechanisms associated with their persistence and may be amenable to similar treatment, whether behavioral or pharmacologic. ICSD-R and DSM-IV categories imply that there are different pathways in these insomnia subtypes. This may not be correct. Clearly, further rigorous investigation is required to investigate "continuum versus category" hypotheses, but our results suggest that insomnia associated with depression or anxiety may simply be a more severe variant of PI. This would make sense in the context of insomnia being a risk factor for depressive illness. 21 However, an alternative explanation is that the absence of difference between the insomnia groups reflects an orthogonal relationship between insomnia and depression. There may be commonalities in insomnia just as the diagnosis of a major depressive disorder follows the same criteria regardless of whether it is "primary" or "associated with" other conditions. Therefore, both the "severity continuum" and "orthogonal construct" hypotheses appear to merit further consideration.
Further comparative work is required to replicate our findings using concomitant measures of behavior, cognition, and physiology relevant to the insomniac experience. Ideally, self-report, observational, and psychophysiologic measures should be gathered independently of one another, in order to limit the method variance associated with using any 1 form of data gathering on its own. In particular, we would like to highlight the outstanding need for better measurement, and component investigation, of the stimulus-control paradigm. The SBSRS-R may be a useful scale to describe and quantify sleep-related behavior, but it does not assess the critically important relationship between behavior and consequence. Inadequate stimulus control is central to diagnostic conceptualization of PI, 2 and stimulus-control treatment is the best evidenced nonpharmacologic intervention, 25 yet we still lack evidence that sleep and bedroom cues are actually associated with differential conditioning in insomnia.
Finally, if our finding is confirmed that it is primarily "effortful preoccupation with sleep" that best discriminates people with insomnia from GS, then perhaps it would be productive for researchers to spend more time studying normalcy, ie, the (perhaps relatively unremarkable) nighttime behavior, beliefs, attitudes, efforts, and physiologic responses of GS. After all, the ultimate goal of insomnia therapies should be to reinstate good sleep, not simply to achieve statistically or even clinically significant change.
